Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.
At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.
So, how can the PCOS Association help?
We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.
Here’s what you’ll find at PCOSA:
✅ Reliable, science-backed information about what PCOS is (and isn’t)
💬 Supportive communities of people who understand exactly what you’re going through
🧬 Resources for navigating fertility, metabolic health, nutrition, and more
🧠 Education for providers who want to better support their PCOS patients
🙋♀️ Advocacy to make sure PCOS is recognized, researched, and respected
No fluff. No fad cures. Just real support, grounded in evidence and compassion.
At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.
pcos: Latest results from PubMed
CONCLUSION: Anxiety affects nearly one-third of Chinese women with PCOS, with prevalence shaped by age, region, and assessment methodologies. Despite alignment with global trends, regional disparities underscore the need for culturally adapted mental health interventions. Clinicians should prioritize anxiety screening in PCOS management, particularly for younger women and underserved populations.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Zhenzhen Hong, Shanshan Hong, Liying Chen, Meiling Liang, Ming Li, Jiawei Qin,
CONCLUSION: Obese patients derived the greatest benefit from nutritional intervention. Higher BMI was associated with better outcomes, particularly among younger patients and those with less ovarian enlargement. These findings support the use of personalized nutrition strategies to enhance treatment efficacy in PCOS management.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Shujun Ma, Wanliang Chen,
CONCLUSION: This study shows a high prevalence of anxiety and depression in PCOS patients, negatively impacting their QoL. Early screening for psychological symptoms is recommended to reduce severe anxiety, major depression, and suicidal incidence, thereby improving patient productivity and QoL.
Published on: Fri, 27 Mar 2026 06:00:00 -0400
Authors: Neha Gupta, Ambrish Kumar Mishra, Pushp Lata Sankhwar, Tripti Kumari,
CONCLUSION: The integration of biomedically-relevant concepts improves the interpretability of PCOS predictions while maintaining predictive performance.
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Sudeepti Kulshrestha, Neeraj Kumar, Pulkit Verma, Kriti Sikri, Mayank Gangwar, Abhishek Sengupta, Suruchi Aggarwal, Priyanka Narad,
No abstract
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Charlotta Klevedal, Yücel Cengiz, Marie Bixo, Sahruh Turkmen,
CONCLUSION: Current evidence suggests that preconceptional or early-pregnancy exposure to GLP-1-based therapies is not consistently associated with increased maternal, fetal, or neonatal risk, although data on continued use throughout gestation remain limited.
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Lasin Ozbek, Ermeena Shah, Rama Al-Shiab, Azra Inal, Mustafa Guldan, Baris Afsar, Adrian Covic, Mehmet Kanbay,
Asialoglycoprotein receptor 1 regulates the inflammatory response in granulosa cells associated with polycystic ovary syndrome. In the granulosa cells of individuals with polycystic ovary syndrome, elevated levels of asialoglycoprotein receptor 1 may activate the extracellular signal-regulated kinase 1/2 (ERK1/2) signaling pathway, which in turn enhances the expression of prostaglandin-endoperoxide synthase 2. Abstract This study evaluated whether asialoglycoprotein receptor 1 (ASGR1) can...
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Xitong Liu, Ting Sun,
Reproductive disorders such as endometriosis and polycystic ovary syndrome (PCOS) are increasingly recognized as immune-mediated conditions, yet their immunopathology remains poorly understood. Menstrual blood, a noninvasive and biologically relevant sample, offers a unique window into reproductive tract immunity but has been underutilized in this context. We optimized Cytek's® 25-color high-dimensional flow cytometry panel by incorporating a mitochondrial dye to investigate immune cell profiles...
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Oliver Richards, Megan Cotterell, Catherine A Thornton, April Rees,
INTRODUCTION: To investigate the feasibility of ultrasound-derived fat fraction (UDFF) as an evaluation index for obese women with polycystic ovary syndrome (PCOS).
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: LingZhi Meng, JinXia Wang, WenJing Liu, Yue Qin, Zongli Yang, Yan Xu,
Polycystic ovary syndrome (PCOS) constitutes a prevalent endocrine and metabolic disorder that substantially compromises reproductive and metabolic health in women of reproductive age. The escalating global prevalence of this multisystem condition underscores the need for innovative, interdisciplinary management strategies. Unlike existing reviews, this paper offers a distinctive synthesis of recent advances in PCOS clinical management, with a novel focus on integrating lifestyle modifications,...
Published on: Thu, 26 Mar 2026 06:00:00 -0400
Authors: Tong Wang, Tianhong Zhang, Jingyuan Wang, Tao Lu,
CONCLUSION: Overall, biomarkers of oxidative stress improved in the metformin-only, melatonin, and sildenafil groups, suggesting that these drugs may have protective effects in PCOS patients. However, further studies are needed to determine their effectiveness.
Published on: Wed, 25 Mar 2026 06:00:00 -0400
Authors: Mohammad Farajneia Hosseinabad, Elahe Masnavi, Parvin Alsadat Eslamnik, Ali Taheri Mirghaed, Elahe Piraee, Asma Siavashpour, Zahra Asadikalemeh, Amir Hossein Doustimotlagh,
Androgens, comparable in importance to estrogens, are essential for female reproductive and physiological health. Polycystic ovary syndrome (PCOS), often caused by elevated testosterone (the primary androgen in females) is characterized by reproductive dysfunction, infertility, and metabolic abnormalities. However, current testosterone assays remain invasive, technically complex, and insufficiently sensitive, limiting their utility for early and noninvasive PCOS screening. This study developed a...
Published on: Wed, 25 Mar 2026 06:00:00 -0400
Authors: Jiaqi Liu, Jing Wang, Litong Chen, Yongxiang Ji, Benxing Su, Geng Zhong, Renfeng Dong, Tailin Xu,
CONCLUSION: The findings reveal a high prevalence of impaired QOL and EDs in women with PCOS, with cultural and marital status differences warranting tailored interventions.
Published on: Wed, 25 Mar 2026 06:00:00 -0400
Authors: Mouna Elleuch, Yesmine Elloumi, Imen Turki, Khouloud Boujelbene, Hamdi Frikha, Nadia Charfi, Mouna Mnif, Faten Hadj Kacem, Dhouha Ben Salah, Nabila Mejdoub Rekik,
This study evaluated Glycyrrhizaglabra (licorice) supplementation's therapeutic efficacy in polycystic ovarian syndrome (PCOS) by assessing its impact on clinical and biochemical parameters, including metabolic and inflammatory markers.
Published on: Wed, 25 Mar 2026 06:00:00 -0400
Authors: Sabreen S Salman Al Anei, Ahmed R Abu Raghif, Hala A Almoayed,
This review article explores the psychological dimension of gynecological disorders in girls and young women, emphasizing the need for interdisciplinary approaches in medical care. Gynecological conditions such as endometriosis, polycystic ovary syndrome (PCOS), and disorders of sex development (DSD) often co-occur with psychological challenges including depression, anxiety, body image issues, and identity-related stress. The chronic nature of symptoms, delayed diagnosis, and potential...
Published on: Wed, 25 Mar 2026 06:00:00 -0400
Authors: Katarzyna Zborowska, Bożena Chrapkiewicz-Knebel, Agnieszka Drosdzol-Cop,